Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fushen Formula
- Development stage
- Preclinical
- Lead developer
- First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
- Administration
- Oral
01
Overview
Fushen Formula is a Traditional Chinese Medicine (TCM) granule formulation composed of several herbal ingredients: Tangerine peel, Qingpinellia, Epimedium, Salvia miltiorrhiza, Angelica, Astragalus membranaceus, Cooked rhubarb, and Guolianyu. It is being investigated for its potential to improve abdominal immune function in patients with peritoneal dialysis-associated peritonitis, primarily through intervention of intestinal flora and metabolites. The formula is administered orally as an adjunct to conventional Western medicine antibiotic therapy.
Beyond the preview
Go deeper on Fushen Formula.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Fushen Formula.